Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Price to Cash Earnings (PCE)

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   PCE(x) 8.278.046.454.557.67

What is the latest Price to Cash Earnings (PCE) ratio of LINCOLN PHARMACEUTICALS ?

The latest Price to Cash Earnings (PCE) ratio of LINCOLN PHARMACEUTICALS is 8.27 based on Mar2023 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar20238.27
Mar20228.04
Mar20216.45
Mar20204.55
Mar20197.67

How is Price to Cash Earnings (PCE) of LINCOLN PHARMACEUTICALS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2023 8.27
2.86
Mar2022 8.04
24.65
Mar2021 6.45
41.76
Mar2020 4.55
-40.68
Mar2019 7.67 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare Price to Cash Earnings (PCE) ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,164.5 Cr -3.7% -4.6% 47.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹363,535.0 Cr 0.9% -6.6% 58.8% Stock Analytics
CIPLA ₹112,058.0 Cr -1% -5.6% 54.6% Stock Analytics
DR REDDYS LABORATORIES ₹104,414.0 Cr 0.9% 2.2% 27.3% Stock Analytics
DIVIS LABORATORIES ₹103,845.0 Cr -2.2% 6.2% 21.2% Stock Analytics
ZYDUS LIFESCIENCES ₹98,676.3 Cr 2.8% -0.6% 96.2% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-3.7%

-4.6%

47.7%

SENSEX

-1.6%

-0.5%

19.8%


You may also like the below Video Courses